Kestra Medical Technologies, Ltd.
NASDAQ:KMTSMedical - Instruments & Supplies
-$0.07 today
- Market cap
- $1.69B
- Beta
- 0.83
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$2.74
Volume 0.44M
Average 0.33M
KMTS Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Kestra Medical Technologies, Ltd.NASDAQ: KMTS
Other Current Assets · Q3 FY2026 · quarter ended Jan 2026
Other current assets rises 241.7% from a year ago
Other current assets stood at $1.49M at the end of Q3 FY2026, up 241.7% from a year earlier and down 84.4% from the prior quarter.
Context
- Other current assets amounted to 0.4% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Other current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current assets keeps rising in the next quarterly balance sheet after a +241.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.69M USD
- Year-over-year change
- +304.1%
- 5-year CAGR
- +52.0%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-04-30 | 1.69M | +304.1% |
| FY2024 | 2024-04-30 | 419K | +124.0% |
| FY2023 | 2023-04-30 | (1.74M) | — |
| FY2021 | 2021-04-30 | 1.35M | +543.5% |
| FY2020 | 2020-04-30 | 209K | — |
Other Current Assets vs competitors
How KMTS compares with its peers on the latest reported figures
- KMTS's Jan 2026 other current assets of $1.49M is the lowest of the 3 companies compared; the peer median is $34.04M.
- Its year-over-year change of +241.7% is the highest of 3, against a peer median of +123.3%.
- Other current assets amounts to 0.4% of total assets for KMTS, versus a peer median of 4.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $65.14M | +241.0% | +27.1% | 6.0% | |
| Mar 2026 | $2.94M | +5.7% | -10.1% | 2.9% | |
| Jan 2026 | $1.49M | +241.7% | — | 0.4% | |
| Peer median (excluding KMTS) | $34.04M | +123.3% | +8.5% | 4.5% | |
Competitors are the stored peer set for KMTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2020 Apr 2020 | FY2021 Apr 2021 | FY2023 Apr 2023 | FY2024 Apr 2024 | FY2025 Apr 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5.76M | 24.34M | 14.81M | 8.25M | 237.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 2.11M | 2M | 8.08M |
| Inventory | 0 | 0 | 2.11M | 3.29M | 6.57M |
| Other Current Assets | 209K | 1.35M | (1.74M) | 419K | 1.69M |
| Total Current Assets | 6.17M | 26.2M | 18.42M | 14.91M | 255.33M |
| Property, Plant & Equipment (Net) | 1.13M | 3.08M | 16.72M | 28.39M | 36.91M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 580K | 1.24M | 3.51M | 2.65M | 3.51M |
| Total Non-current Assets | 1.71M | 4.33M | 20.23M | 31.04M | 40.42M |
| Total Assets | 7.87M | 30.52M | 38.66M | 45.95M | 295.74M |
| Account Payables | 1.83M | 1.7M | 6.16M | 23.89M | 23.96M |
| Short-term Debt | 0 | 0 | 20.45M | 0 | 187K |
| Tax Payables | 68K | 42K | 215K | 234K | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 4.67M | 6.19M | 8.49M |
| Total Current Liabilities | 4.02M | 6.61M | 36.74M | 32.97M | 37.98M |
| Long-term Debt | 0 | 20.24M | 17.32M | 42.54M | 41.1M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 360K | 102.17M | 177.19M | 8.24M |
| Total Non-current Liabilities | 0 | 22.15M | 119.5M | 222.36M | 52.36M |
| Total Liabilities | 4.02M | 28.76M | 156.23M | 255.33M | 90.34M |
| Common Stock | 1K | 1K | 1K | 1K | 51.35M |
| Retained Earnings | (135.98M) | (170.08M) | (312.32M) | (406.44M) | (520.25M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 3.86M | 1.77M | (117.58M) | (209.38M) | 205.41M |
| Total Debt | 452K | 22.85M | 39.13M | 45.17M | 44.31M |
| Net Debt | (5.3M) | (1.49M) | 24.32M | 36.92M | (193.28M) |
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
Intrinsic Alpha fair value
Locked
Current Price
$28.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.